Literature DB >> 15270844

T cell-derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infection.

B M Saunders1, H Briscoe, W J Britton.   

Abstract

Tumour necrosis factor (TNF) is critical for sustained protective immunity against Mycobacterium tuberculosis infection. To investigate the relative contributions of macrophage- and T cell-derived TNF towards this immunity T cells from wild-type (WT) or TNF-/- mice were transferred into RAG-/- or TNF-/- mice which were then infected with M. tuberculosis. Infected RAG-/- mice and RAG-/- recipients of TNF deficient T cells developed overwhelming infection, with extensive pulmonary and hepatic necrosis and succumbed with a median of only 16 days infection. By contrast, RAG-/- recipients of WT T cells showed a significant increase in survival with a median of 32 days. Although initial bacterial growth was similar in all groups of RAG-/- mice, the transfer of WT, but not TNF-/-, T cells led to the formation of discrete foci of leucocytes and macrophages and delayed the development of necrotizing pathology. To determine requirements for macrophage-derived TNF, WT or TNF-/- T cells were transferred into TNF-/- mice at the time of M. tuberculosis infection. Transfer of WT T cells significantly prolonged survival and reduced the early tissue necrosis evident in the TNF-/- mice, however, these mice eventually succumbed indicating that T cell-derived TNF alone is insufficient to control the infection. Therefore, both T cell- and macrophage-derived TNF play distinct roles in orchestrating the protective inflammatory response and enhancing survival during M. tuberculosis infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15270844      PMCID: PMC1809113          DOI: 10.1111/j.1365-2249.2004.02518.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Interleukin 10 produced by macrophages inoculated with Mycobacterium avium attenuates mycobacteria-induced apoptosis by reduction of TNF-alpha activity.

Authors:  M K Balcewicz-Sablinska; H Gan; H G Remold
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

2.  TNF-alpha associated with extracellular matrix fibronectin provides a stop signal for chemotactically migrating T cells.

Authors:  S Franitza; R Hershkoviz; N Kam; N Lichtenstein; G G Vaday; R Alon; O Lider
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

3.  Differential effects of TNF and LTalpha in the host defense against M. bovis BCG.

Authors:  M Bopst; I Garcia; R Guler; M L Olleros; T Rülicke; M Müller; S Wyss; K Frei; M Le Hir; H P Eugster
Journal:  Eur J Immunol       Date:  2001-06       Impact factor: 5.532

4.  Correction of defective host response to Mycobacterium bovis BCG infection in TNF-deficient mice by bone marrow transplantation.

Authors:  M Jacobs; M W Marino; N Brown; B Abel; L G Bekker; V J Quesniaux; L Fick; B Ryffel
Journal:  Lab Invest       Date:  2000-06       Impact factor: 5.662

Review 5.  TNF signaling in vascular endothelial cells.

Authors:  L A Madge; J S Pober
Journal:  Exp Mol Pathol       Date:  2001-06       Impact factor: 3.362

Review 6.  Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix.

Authors:  G G Vaday; S Franitza; H Schor; I Hecht; A Brill; L Cahalon; R Hershkoviz; O Lider
Journal:  J Leukoc Biol       Date:  2001-06       Impact factor: 4.962

Review 7.  Macrophage apoptosis in mycobacterial infections.

Authors:  C Fratazzi; R D Arbeit; C Carini; M K Balcewicz-Sablinska; J Keane; H Kornfeld; H G Remold
Journal:  J Leukoc Biol       Date:  1999-11       Impact factor: 4.962

8.  Fibronectin-bound TNF-alpha stimulates monocyte matrix metalloproteinase-9 expression and regulates chemotaxis.

Authors:  G G Vaday; R Hershkoviz; M A Rahat; N Lahat; L Cahalon; O Lider
Journal:  J Leukoc Biol       Date:  2000-11       Impact factor: 4.962

9.  Outside-to-inside signal through the membrane TNF-alpha induces E-selectin (CD62E) expression on activated human CD4+ T cells.

Authors:  S Harashima; T Horiuchi; N Hatta; C Morita; M Higuchi; T Sawabe; H Tsukamoto; T Tahira; K Hayashi; S Fujita; Y Niho
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

10.  Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology.

Authors:  V P Mohan; C A Scanga; K Yu; H M Scott; K E Tanaka; E Tsang; M M Tsai; J L Flynn; J Chan
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

View more
  26 in total

1.  The tumor necrosis factor receptor stalk regions define responsiveness to soluble versus membrane-bound ligand.

Authors:  Christine Richter; Sylvia Messerschmidt; Gerlinde Holeiter; Jessica Tepperink; Sylvia Osswald; Andrea Zappe; Marcus Branschädel; Verena Boschert; Derek A Mann; Peter Scheurich; Anja Krippner-Heidenreich
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

Review 2.  Innate and Adaptive Cellular Immune Responses to Mycobacterium tuberculosis Infection.

Authors:  Katrin D Mayer-Barber; Daniel L Barber
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-17       Impact factor: 6.915

3.  Differential risk of tuberculosis reactivation among anti-TNF therapies is due to drug binding kinetics and permeability.

Authors:  Mohammad Fallahi-Sichani; JoAnne L Flynn; Jennifer J Linderman; Denise E Kirschner
Journal:  J Immunol       Date:  2012-02-29       Impact factor: 5.422

4.  Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity.

Authors:  Laura E Swaim; Lynn E Connolly; Hannah E Volkman; Olivier Humbert; Donald E Born; Lalita Ramakrishnan
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

5.  Post-treatment change in Mycobacterium tuberculosis antigen-stimulated tumor necrosis factor-alpha release in patients with active tuberculosis.

Authors:  Chang Ho Kim; Seung Soo Yoo; Shin Yup Lee; Seung Ick Cha; Jae Yong Park; Jaehee Lee
Journal:  J Thorac Dis       Date:  2015-05       Impact factor: 2.895

Review 6.  Latent tuberculosis infection: myths, models, and molecular mechanisms.

Authors:  Noton K Dutta; Petros C Karakousis
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

7.  Innate and adaptive interferons suppress IL-1α and IL-1β production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection.

Authors:  Katrin D Mayer-Barber; Bruno B Andrade; Daniel L Barber; Sara Hieny; Carl G Feng; Patricia Caspar; Sandy Oland; Siamon Gordon; Alan Sher
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

8.  Modulation of Roquin Function in Myeloid Cells Reduces Mycobacterium tuberculosis-Induced Inflammation.

Authors:  Gayathri Nagalingam; Carola G Vinuesa; Warwick J Britton; Bernadette M Saunders
Journal:  J Immunol       Date:  2017-07-26       Impact factor: 5.422

Review 9.  In search of a new paradigm for protective immunity to TB.

Authors:  Cláudio Nunes-Alves; Matthew G Booty; Stephen M Carpenter; Pushpa Jayaraman; Alissa C Rothchild; Samuel M Behar
Journal:  Nat Rev Microbiol       Date:  2014-03-03       Impact factor: 60.633

Review 10.  Mechanisms of M. tuberculosis Immune Evasion as Challenges to TB Vaccine Design.

Authors:  Joel D Ernst
Journal:  Cell Host Microbe       Date:  2018-07-11       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.